title: Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion.
authors: Ulrich A
authors: UA
authors: Walker
authors: Delphine S
authors: DS
authors: Courvoisier
authors: Jean
authors: J
authors: Dudler
authors: Daniel
authors: D
authors: Aeberli
authors: Johannes
authors: J
authors: von Kempis
authors: Almut
authors: A
authors: Scherer
authors: Axel
authors: A
authors: Finckh
mesh_terms: D000069594:Abatacept; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001402:B-Lymphocytes / Q000187:drug effects*; D001688:Biological Products / Q000009:adverse effects*; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D013557:Switzerland
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D018796:Immunoconjugates; D000069594:Abatacept